SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2025-03-04 15:48
Tx date 2022-09-13 		$MSCL
Satellos Bioscience Inc. 		Gleeson, Francis (Frank) Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 6857990 Canada Inc. (Control or Direction)
Common Shares
15 - Acquisition or disposition under a prospectus 		$100,000
+250,000 vol
$0.40 each 		250,000
Filed 2025-03-04 12:42
Tx date 2024-12-20 		$MSCL
Satellos Bioscience Inc. 		Gleeson, Francis (Frank) Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 6857990 Canada Inc. (Control or Direction)
Common Shares
15 - Acquisition or disposition under a prospectus 		$144,000
+160,000 vol
$0.90 each 		488,169
Filed 2024-12-20 17:07
Tx date 2024-12-20 		$MSCL
Satellos Bioscience Inc. 		Gleeson, Francis (Frank) Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
15 - Acquisition or disposition under a prospectus 		$144,000
+160,000 vol
$0.90 each
Filed 2022-09-14 09:01
Tx date 2022-09-13 		$MSCL
Satellos Bioscience Inc. 		Gleeson, Francis (Frank) Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
15 - Acquisition or disposition under a prospectus 		$100,000
+250,000 vol
$0.40 each
Filed 2025-02-18 09:19
Tx date 2025-02-10 		$MSCL
Satellos Bioscience Inc. 		Gleeson, Francis (Frank) Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$2,237,891
+2,832,774 vol
$0.79 each 		6,195,691
Filed 2024-12-20 17:07
Tx date 2024-12-20 		$MSCL
Satellos Bioscience Inc. 		Gleeson, Francis (Frank) Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
15 - Acquisition or disposition under a prospectus 		$144,000
+160,000 vol
$0.90 each 		3,648,220
Filed 2024-05-17 11:04
Tx date 2024-05-16 		$MSCL
Satellos Bioscience Inc. 		Gleeson, Francis (Frank) Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$11,280
+24,000 vol
$0.47 each 		3,488,220
Filed 2024-05-17 11:04
Tx date 2024-05-16 		$MSCL
Satellos Bioscience Inc. 		Gleeson, Francis (Frank) Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$2,325
+5,000 vol
$0.465 each 		3,464,220
Filed 2024-05-02 15:13
Tx date 2024-05-02 		$MSCL
Satellos Bioscience Inc. 		Gleeson, Francis (Frank) Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$20,421
+47,000 vol
$0.4345 each 		3,459,220
Filed 2023-09-07 16:20
Tx date 2023-09-07 		$MSCL
Satellos Bioscience Inc. 		Gleeson, Francis (Frank) Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 6857990 Canada Inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$8,991
+18,500 vol
$0.486 each 		328,169
Filed 2023-09-07 16:20
Tx date 2023-09-07 		$MSCL
Satellos Bioscience Inc. 		Gleeson, Francis (Frank) Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 6857990 Canada Inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$3,120
+6,500 vol
$0.48 each 		309,669
Filed 2023-09-07 16:19
Tx date 2023-09-07 		$MSCL
Satellos Bioscience Inc. 		Gleeson, Francis (Frank) Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 6857990 Canada Inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$11,485
+25,000 vol
$0.4594 each 		303,169
Filed 2023-09-07 16:19
Tx date 2023-09-07 		$MSCL
Satellos Bioscience Inc. 		Gleeson, Francis (Frank) Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 6857990 Canada Inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$11,252
+25,000 vol
$0.4501 each 		278,169
Filed 2023-09-07 16:18
Tx date 2023-09-07 		$MSCL
Satellos Bioscience Inc. 		Gleeson, Francis (Frank) Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 6857990 Canada Inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$10,625
+25,000 vol
$0.425 each 		253,169
Filed 2023-06-05 10:03
Tx date 2023-06-01 		$MSCL
Satellos Bioscience Inc. 		Gleeson, Francis (Frank) Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+2,108,517 vol 		3,362,917
Filed 2023-05-19 15:25
Tx date 2023-05-17 		$MSCL
Satellos Bioscience Inc. 		Gleeson, Francis (Frank) Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 6857990 Canada Inc. (Control or Direction)
Common Shares
15 - Acquisition or disposition under a prospectus 		$100,000
+200,000 vol
$0.50 each 		228,169
Filed 2023-03-28 10:25
Tx date 2023-03-24 		$MSCL
Satellos Bioscience Inc. 		Gleeson, Francis (Frank) Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 6857990 Canada Inc. (Control or Direction)
Debentures
16 - Acquisition or disposition under a prospectus exemption
+$100,000 vol 		$100,000
Filed 2023-03-28 10:20
Tx date 2021-08-13 		$MSCL
Satellos Bioscience Inc. 		Gleeson, Francis (Frank) Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 6857990 Canada Inc. (Control or Direction)
Debentures
00 - Opening Balance-Initial SEDI Report
Filed 2023-03-28 10:20
Tx date 2023-03-24 		$MSCL
Satellos Bioscience Inc. 		Gleeson, Francis (Frank) Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 6857990 Canada Inc. (Control or Direction)
Common Shares
16 - Acquisition or disposition under a prospectus exemption
+28,169 vol 		28,169
Filed 2023-03-28 10:17
Tx date 2021-08-13 		$MSCL
Satellos Bioscience Inc. 		Gleeson, Francis (Frank) Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 6857990 Canada Inc. (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2022-10-06 17:14
Tx date 2022-10-06 		$MSCL
Satellos Bioscience Inc. 		Gleeson, Francis (Frank) Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+270,000 vol 		1,254,400
Filed 2022-09-14 09:03
Tx date 2022-09-13 		$MSCL
Satellos Bioscience Inc. 		Gleeson, Francis (Frank) Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
15 - Acquisition or disposition under a prospectus 		$50,000
+125,000 vol
$0.40 each 		125,000
Filed 2022-09-14 09:02
Tx date 2021-08-13 		$MSCL
Satellos Bioscience Inc. 		Gleeson, Francis (Frank) Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2022-09-14 09:01
Tx date 2022-09-13 		$MSCL
Satellos Bioscience Inc. 		Gleeson, Francis (Frank) Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
15 - Acquisition or disposition under a prospectus 		$100,000
+250,000 vol
$0.40 each 		3,412,220
Filed 2022-02-23 16:14
Tx date 2022-02-10 		$MSCL
Satellos Bioscience Inc. 		Gleeson, Francis (Frank) Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-34,720
-40,000 vol
$0.87 each 		3,122,220
Filed 2022-02-22 16:19
Tx date 2022-02-14 		$MSCL
Satellos Bioscience Inc. 		Gleeson, Francis (Frank) Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-34,720
-40,000 vol
$0.87 each
Filed 2022-02-22 16:23
Tx date 2022-02-22 		$MSCL
Satellos Bioscience Inc. 		Gleeson, Francis (Frank) Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$34,572
+40,000 vol
$0.86 each 		3,162,220
Filed 2022-02-22 16:22
Tx date 2022-02-22 		$MSCL
Satellos Bioscience Inc. 		Gleeson, Francis (Frank) Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately 		$34,572
+40,000 vol
$0.86 each
Filed 2022-02-22 16:19
Tx date 2022-02-22 		$MSCL
Satellos Bioscience Inc. 		Gleeson, Francis (Frank) Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately 		$34,572
+40,000 vol
$0.86 each
Filed 2022-02-22 16:19
Tx date 2022-02-14 		$MSCL
Satellos Bioscience Inc. 		Gleeson, Francis (Frank) Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-34,720
-40,000 vol
$0.87 each 		3,122,220
Filed 2022-01-25 14:27
Tx date 2022-01-25 		$MSCL
Satellos Bioscience Inc. 		Gleeson, Francis (Frank) Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$20,493
+20,700 vol
$0.99 each 		3,162,220
Filed 2022-01-25 14:26
Tx date 2022-01-25 		$MSCL
Satellos Bioscience Inc. 		Gleeson, Francis (Frank) Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$7,275
+7,500 vol
$0.97 each 		3,141,520
Filed 2022-01-25 14:26
Tx date 2022-01-25 		$MSCL
Satellos Bioscience Inc. 		Gleeson, Francis (Frank) Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$2,660
+2,800 vol
$0.95 each 		3,134,020
Filed 2022-01-24 14:06
Tx date 2022-01-24 		$MSCL
Satellos Bioscience Inc. 		Gleeson, Francis (Frank) Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$9,300
+10,000 vol
$0.93 each 		3,131,220
Filed 2022-01-24 14:05
Tx date 2022-01-24 		$MSCL
Satellos Bioscience Inc. 		Gleeson, Francis (Frank) Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$2,350
+2,500 vol
$0.94 each 		3,121,220
Filed 2022-01-24 14:05
Tx date 2022-01-24 		$MSCL
Satellos Bioscience Inc. 		Gleeson, Francis (Frank) Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$2,325
+2,500 vol
$0.93 each 		3,118,720
Filed 2022-01-24 14:04
Tx date 2022-01-24 		$MSCL
Satellos Bioscience Inc. 		Gleeson, Francis (Frank) Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$4,600
+5,000 vol
$0.92 each 		3,116,220
Filed 2021-10-19 14:49
Tx date 2021-10-13 		$MSCL
Satellos Bioscience Inc. 		Gleeson, Francis (Frank) Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$63,652
+40,000 vol
$1.59 each 		3,111,220
Filed 2021-09-23 10:32
Tx date 2021-08-13 		$MSCL
Satellos Bioscience Inc. 		Gleeson, Francis (Frank) Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		984,400
Filed 2021-09-23 10:32
Tx date 2021-08-13 		$MSCL
Satellos Bioscience Inc. 		Gleeson, Francis (Frank) Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report 		3,071,220
Filed 2021-09-23 10:31
Tx date 2021-08-13 		$
Satellos Bioscience Inc. 		Gleeson, Francis (Frank) Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2021-09-23 10:31
Tx date 2021-08-13 		$
Satellos Bioscience Inc. 		Gleeson, Francis (Frank) Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2021-08-19 17:30
Tx date 2021-08-13 		$
Satellos Bioscience Inc. 		Gleeson, Francis (Frank) Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2021-08-19 17:29
Tx date 2021-08-13 		$
Satellos Bioscience Inc. 		Gleeson, Francis (Frank) Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2021-08-19 17:30
Tx date 2021-08-13 		$MSCL
Satellos Bioscience Inc. 		Gleeson, Francis (Frank) Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		984,400
Filed 2021-08-19 17:29
Tx date 2021-08-13 		$MSCL
Satellos Bioscience Inc. 		Gleeson, Francis (Frank) Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report 		3,071,220